Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action
- 24 June 2008
- journal article
- case report
- Published by Wiley in Arthritis Care & Research
- Vol. 59 (7), 996-1001
- https://doi.org/10.1002/art.23835
Abstract
Objective Numerous reports of the induction or worsening of psoriasis in patients treated with tumor necrosis factor (TNF) antagonists indicate that this is not a rare phenomenon. The etiology of this paradoxical clinical response remains unclear. The aim of this study was to describe similar cases, conduct a comprehensive analysis of the literature, explore possible immunologic mechanisms of action of this perplexing reaction, and recommend management options. Methods A systematic literature review was performed using the PubMed and Medline databases (1996 to September 2007) searching the index terms “infliximab,” “etanercept,” “adalimumab,” “tumor necrosis factor alpha inhibitor,” and “TNF inhibitor,” combined with the terms “psoriasis,” “pustular,” “skin,” “rash,” and “palmoplantar.” All relevant articles in English were reviewed. Pertinent secondary references were also analyzed. Results According to the literature, new‐onset psoriasis may occur any time after initiation of TNF antagonist therapy, is often of an uncommon morphology, may respond to psoriasis treatments, and usually resolves with TNF discontinuation. The pathogenesis of this response appears to involve a disruption in cytokine balance following TNF inhibition, resulting in the up‐regulation of plasmacytoid dendritic cells and the subsequent production of unopposed interferon‐α, following a triggering event in predisposed individuals. Conclusion TNF antagonist–induced psoriasis is a newly recognized adverse effect of these medications that typically does not require therapy cessation. We recommend aggressive treatment of the skin disease and consideration of a change in the TNF antagonist if the lesions are unresponsive to conventional psoriasis treatment.Keywords
This publication has 38 references indexed in Scilit:
- Psoriasiform and pustular eruption induced by infliximabThe Journal of Dermatology, 2007
- Potential Complications Associated with the Use of Biologic Agents for PsoriasisDermatologic Clinics, 2007
- Survenue d’un psoriasis au cours d’un traitement par infliximab pour fasciite de ShulmanAnnales de Dermatologie et de Vénéréologie, 2007
- Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockersClinical and Experimental Dermatology, 2007
- Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-? antagonistsBritish Journal of Dermatology, 2007
- Psoriasis and Pustular Dermatitis Triggered by TNF-α Inhibitors in Patients With Rheumatologic ConditionsArchives of Dermatology, 2007
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Increased Sensitivity to Interferon-α in Psoriatic T CellsJournal of Investigative Dermatology, 2005
- Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective studyArthritis Research & Therapy, 2005
- Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2003